FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075273313> ?p ?o ?g. }

• W2075273313 endingPage "2959" @default.
• W2075273313 startingPage "2945" @default.
• W2075273313 abstract "The discovery of 1,3,8-triazaspiro[4.5]decane-2,4-diones (spirohydantoins) as a structural class of pan-inhibitors of the prolyl hydroxylase (PHD) family of enzymes for the treatment of anemia is described. The initial hit class, spirooxindoles, was identified through affinity selection mass spectrometry (AS-MS) and optimized for PHD2 inhibition and optimal PK/PD profile (short-acting PHDi inhibitors). 1,3,8-Triazaspiro[4.5]decane-2,4-diones (spirohydantoins) were optimized as an advanced lead class derived from the original spiroindole hit. A new set of general conditions for C–N coupling, developed using a high-throughput experimentation (HTE) technique, enabled a full SAR analysis of the spirohydantoins. This rapid and directed SAR exploration has resulted in the first reported examples of hydantoin derivatives with good PK in preclinical species. Potassium channel off-target activity (hERG) was successfully eliminated through the systematic introduction of acidic functionality to the molecular structure. Undesired upregulation of alanine aminotransferese (ALT) liver enzymes was mitigated and a robust on-/off-target margin was achieved. Spirohydantoins represent a class of highly efficacious, short-acting PHD1–3 inhibitors causing a robust erythropoietin (EPO) upregulation in vivo in multiple preclinical species. This profile deems spirohydantoins as attractive short-acting PHDi inhibitors with the potential for treatment of anemia." @default.
• W2075273313 created "2016-06-24" @default.
• W2075273313 creator A5002482553 @default.
• W2075273313 creator A5004168852 @default.
• W2075273313 creator A5005917074 @default.
• W2075273313 creator A5026055012 @default.
• W2075273313 creator A5026604505 @default.
• W2075273313 creator A5029601068 @default.
• W2075273313 creator A5035314120 @default.
• W2075273313 creator A5036570397 @default.
• W2075273313 creator A5037240771 @default.
• W2075273313 creator A5039455069 @default.
• W2075273313 creator A5041075490 @default.
• W2075273313 creator A5042058753 @default.
• W2075273313 creator A5044265007 @default.
• W2075273313 creator A5044492376 @default.
• W2075273313 creator A5044511961 @default.
• W2075273313 creator A5047129407 @default.
• W2075273313 creator A5047712941 @default.
• W2075273313 creator A5055486511 @default.
• W2075273313 creator A5058810317 @default.
• W2075273313 creator A5062600771 @default.
• W2075273313 creator A5063631885 @default.
• W2075273313 creator A5063648205 @default.
• W2075273313 creator A5070103496 @default.
• W2075273313 creator A5070630218 @default.
• W2075273313 creator A5070964859 @default.
• W2075273313 creator A5073414350 @default.
• W2075273313 creator A5078142125 @default.
• W2075273313 creator A5078303735 @default.
• W2075273313 creator A5079153351 @default.
• W2075273313 creator A5091123974 @default.
• W2075273313 creator A5091610692 @default.
• W2075273313 date "2012-02-27" @default.
• W2075273313 modified "2023-09-26" @default.
• W2075273313 title "1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1–3 (HIF PHD1–3) for the Treatment of Anemia" @default.
• W2075273313 cites W1485773682 @default.
• W2075273313 cites W1970907396 @default.
• W2075273313 cites W2016578094 @default.
• W2075273313 cites W2031638748 @default.
• W2075273313 cites W2035855731 @default.
• W2075273313 cites W2042624112 @default.
• W2075273313 cites W2052201224 @default.
• W2075273313 cites W2059951197 @default.
• W2075273313 cites W2060277684 @default.
• W2075273313 cites W2062354563 @default.
• W2075273313 cites W2072299843 @default.
• W2075273313 cites W2080304171 @default.
• W2075273313 cites W2092788099 @default.
• W2075273313 cites W2094174301 @default.
• W2075273313 cites W2106987493 @default.
• W2075273313 cites W2111636767 @default.
• W2075273313 cites W2116571550 @default.
• W2075273313 cites W2123200029 @default.
• W2075273313 cites W2126806779 @default.
• W2075273313 cites W2128786395 @default.
• W2075273313 cites W2144139453 @default.
• W2075273313 cites W2149736876 @default.
• W2075273313 cites W2150097532 @default.
• W2075273313 doi "https://doi.org/10.1021/jm201542d" @default.
• W2075273313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22364528" @default.
• W2075273313 hasPublicationYear "2012" @default.
• W2075273313 type Work @default.
• W2075273313 sameAs 2075273313 @default.
• W2075273313 citedByCount "53" @default.
• W2075273313 countsByYear W20752733132012 @default.
• W2075273313 countsByYear W20752733132013 @default.
• W2075273313 countsByYear W20752733132014 @default.
• W2075273313 countsByYear W20752733132015 @default.
• W2075273313 countsByYear W20752733132016 @default.
• W2075273313 countsByYear W20752733132017 @default.
• W2075273313 countsByYear W20752733132018 @default.
• W2075273313 countsByYear W20752733132019 @default.
• W2075273313 countsByYear W20752733132020 @default.
• W2075273313 countsByYear W20752733132021 @default.
• W2075273313 countsByYear W20752733132022 @default.
• W2075273313 countsByYear W20752733132023 @default.
• W2075273313 crossrefType "journal-article" @default.
• W2075273313 hasAuthorship W2075273313A5002482553 @default.
• W2075273313 hasAuthorship W2075273313A5004168852 @default.
• W2075273313 hasAuthorship W2075273313A5005917074 @default.
• W2075273313 hasAuthorship W2075273313A5026055012 @default.
• W2075273313 hasAuthorship W2075273313A5026604505 @default.
• W2075273313 hasAuthorship W2075273313A5029601068 @default.
• W2075273313 hasAuthorship W2075273313A5035314120 @default.
• W2075273313 hasAuthorship W2075273313A5036570397 @default.
• W2075273313 hasAuthorship W2075273313A5037240771 @default.
• W2075273313 hasAuthorship W2075273313A5039455069 @default.
• W2075273313 hasAuthorship W2075273313A5041075490 @default.
• W2075273313 hasAuthorship W2075273313A5042058753 @default.
• W2075273313 hasAuthorship W2075273313A5044265007 @default.
• W2075273313 hasAuthorship W2075273313A5044492376 @default.
• W2075273313 hasAuthorship W2075273313A5044511961 @default.
• W2075273313 hasAuthorship W2075273313A5047129407 @default.
• W2075273313 hasAuthorship W2075273313A5047712941 @default.
• W2075273313 hasAuthorship W2075273313A5055486511 @default.
• W2075273313 hasAuthorship W2075273313A5058810317 @default.
• W2075273313 hasAuthorship W2075273313A5062600771 @default.

• next